Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-30

FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for bupropion hydrochloride extended-release (XL) from Exelan Pharmaceuticals Inc., enabling continued marketing of a ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride extended-release (XL) (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE)